Seyed Mohammad Akrami
Overview
Explore the profile of Seyed Mohammad Akrami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karimi E, Kalaki N, Akrami S
Biochem Biophys Rep
. 2025 Feb;
41:101921.
PMID: 39911529
Background: One of the most aggressive tumors is pancreatic ductal adenocarcinoma (PAAD), which is usually discovered at an advanced stage and is linked to a poor response to current treatment...
2.
Jamali Z, Razipour M, Zargar M, Ghasemnejad-Berenji H, Akrami S
Clin Chim Acta
. 2024 Oct;
565:120011.
PMID: 39437983
Ovarian cancer (OC) remains a significant women's health concern due to its high mortality rate and the challenges posed by late detection. Exploring novel biomarkers could lead to earlier, more...
3.
Materna M, Delmonte O, Bosticardo M, Momenilandi M, Conrey P, Charmeteau-De Muylder B, et al.
Science
. 2024 Feb;
383(6686):eadh4059.
PMID: 38422122
We describe humans with rare biallelic loss-of-function variants impairing pre-α T cell receptor (pre-TCRα) expression. Low circulating naive αβ T cell counts at birth persisted over time, with normal memory...
4.
Vaseghi P, Habibi L, Neidich J, Cao Y, Fattahi N, Rashidi-Nezhad R, et al.
Eur J Hum Genet
. 2024 Jan;
32(10):1238-1249.
PMID: 38278869
Understanding the underlying causes of congenital anomalies (CAs) can be a complex diagnostic journey. We aimed to assess the efficiency of exome sequencing (ES) and chromosomal microarray analysis (CMA) in...
5.
Vaseghi H, Akrami S, Rashidi-Nezhad A
J Clin Lab Anal
. 2023 Oct;
37(17-18):e24967.
PMID: 37823350
Background: Despite the efforts that have been made to standardize the interpretation of variants, in some cases, their pathogenicity remains vague and confusing, and sometimes their interpretation does not help...
6.
Sohrabi N, Habibi L, Akrami S
Iran J Public Health
. 2023 May;
52(3):633-645.
PMID: 37124903
Background: One of the most important endogenous factors causing genomic instability in human cells is L1s retrotransposons. In this study, we assume that increased activity of L1 retrotransposons (specifically L1...
7.
Mahdiannasser M, Rashidi-Nezhad A, Badv R, Akrami S
Acta Neurol Belg
. 2022 Sep;
122(6):1457-1468.
PMID: 36127562
Background: By affecting about 50 million people worldwide, epilepsy is considered a global concern in neurology. Intolerable enough, up to ¼ of all patients do not respond to antiepileptic drugs...
8.
Salmani H, Yahyaei M, Raoofian R, Irani S, Salahshouri Far I, Akrami S
Iran J Public Health
. 2022 Jul;
51(2):450-459.
PMID: 35866114
Background: Mutations of the epidermal growth factor receptor () gene, predominantly in exons 18-21, have been highlighted to function as the crucial predictors of the response rate of patients with...
9.
Amirifar P, Mehrmohamadi M, Ranjouri M, Akrami S, Rezaei N, Saberi A, et al.
J Clin Immunol
. 2021 Oct;
42(1):72-84.
PMID: 34628594
Background: Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by mutations in the ataxia telangiectasia mutated (ATM) gene. A-T patients manifest considerable variability in clinical and immunological features, suggesting...
10.
Ahmadi M, Eftekhari Kenzerki M, Akrami S, Pashangzadeh S, Hajiesmaeili F, Rahnavard S, et al.
FEBS Open Bio
. 2021 Jul;
11(9):2525-2540.
PMID: 34231338
Hypoxanthine phosphoribosyltransferase (HPRT1), as a salvage pathway enzyme, plays a crucial role in modulating the cell cycle and has been reported to be overexpressed in multiple cancers. Nevertheless, the relationship...